Preview

Научно-практическая ревматология

Расширенный поиск

Факторы, влияющие на качество жизни, связанное со здоровьем, у пациентов с системной красной волчанкой

https://doi.org/10.14412/1995-4484-2019-462-467

Полный текст:

Аннотация

Системная красная волчанка (СКВ) – хроническое аутоиммунное заболевание, которое поражает любые органы и системы и характеризуется широким спектром разнообразных клинических проявлений. Согласно стратегии «Лечение до достижения цели» (Treat to Target) при СКВ, помимо контроля активности заболевания и необратимых органных повреждений, необходимо проводить оценку качества жизни, связанного со здоровьем (КЖСЗ), что позволяет получить полную и объективную характеристику пациента. Необходимо также учитывать все те факторы и проблемы, которые могут ухудшать КЖСЗ. В качестве главных симптомов, которые в значительной степени влияют на КЖСЗ, выделяют усталость, боль и депрессию. Также учитывается влияние когнитивных нарушений, связанных с заболеванием. Немаловажной проблемой для больных СКВ является нарушение образа тела, т. е. восприятия своего внешнего облика самим пациентом. Непредсказуемость течения заболевания и нарушение физического функционирования больных затрудняют выполнение повседневных функций, нарушается социализация, пациенты часто испытывают зависимость от других людей. Из-за СКВ пациенты часто ограничены в выборе своей профессии или вынуждены прекращать/менять работу, что приводит к финансовым потерям и ощущению изоляции от общества. Также в обзоре рассматриваются в качестве факторов, влияющих на КЖСЗ, пол, возраст и наличие образования у пациентов с СКВ.

Об авторе

Л. Д. Воробьева
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А Насоновой»
Россия

аспирант ФГБНУ «НИИР им. В.А. Насоновой» (научный руководитель – к.м.н. Е.А. Асеева)

115522, Москва, Каширское шоссе, 34А



Список литературы

1. Majdan M. Toczen rumieniowaty ukladowy w Polsce. Raport. 2012. Access: 4.02.2016.

2. Navarrete-Navarrete N, Peralta-Ramirez MI, Sabio JM, et al. Quality-of-life predictor factors in patients with SLE and their modification after cognitive behavioural therapy. Lupus. 2010;19:1632-9. doi: 10.1177/0961203310378413

3. Alarcon G, McGwin G, Uribe A, et al. Systemic lupus erythematosus in a multiethnic lupus cohort (lumina). XVII. Predictors of self-reported health-related quality of life early in the disease course. Arthritis Rheum. 2004;51:465-74. doi: 10.1002/art.20409

4. Haupt M, Millen S, Janner M, et al. Improvement of coping abilities in patients with systemic lupus erythematosus: a prospective study. Ann Rheum Dis. 2005;64:1618-23. doi: 10.1136/ard.2004.029926

5. Kuriya B, Gladman D, Ibanez D, Urowitz M. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum. 2008;59:181-5. doi: 10.1002/art.23339

6. Lau C, Mak A. The socioeconomic burden of SLE. Nat Rev Rheumatol. 2009;5:400-4. doi: 10.1038/nrrheum.2009.106

7. Krasselt M, Baerwal C. Sex, Symptom Severity, and Quality of Life in Rheumatology. Clin Rev Allerg Immunol. June 2019 Jun;56(3):346-61. doi: 10.1007/s12016-017-8631-6

8. Kiani A, Strand V, Fang H. Predictors of self-reported healthrelated quality of life in systemic lupus erythematosus. Rheumatology. 2013;52:1651-7. doi: 10.1093/rheumatology/ket171

9. Jolly M, Sequeira W. Gender Differences in Quality of Life in Patients with Systemic Lupus Erythematosus. Arthritis Care Res. 2018. doi: 10.1002/acr.23588

10. Kirchengast S, Haslinger B. Gender differences in health-related quality of life among healthy aged and old-aged Austrians: crosssectional analysis. Gend Med. 2008 Sep;5(3):270-8. doi: 10.1016/j.genm.2008.07.001

11. Belbeisi A, Zindah M, Walke HT, et al. Health related quality of life measures by demographics and common health risks. Jordan Int J Pub Health. 2009 Jun;54 Suppl 1:106-10. doi: 10.1007/s00038-009-0014-1

12. Urowitz M, Gladman D, Ibanez D. Changes in Quality of Life in the First 5 Years of Disease in a Multicenter Cohort of Patients With Systemic Lupus Erythematosus. Arthritis Care Res. 2014;66(9):1374-9. doi: 10.1002/acr.22299

13. Rinaldi S, Doria A, Salaffi F. Health-related quality of life in Italian patients with systemic lupus erythematosus. I. Relationship between physical and mental dimension and impact of age. Rheumatology. 2004;43:1574-9. doi: 10.1093/rheumatology/keh397

14. McElhone K, Abbott J, Gray J, et al. Patient perspective of systemic lupus erythematosus in relation to health-related quality of life concepts: a qualitative study. Lupus. 2010;19:1640-7. doi: 10.1177/0961203310378668

15. Bauernfeind B, Aringer M, Prodinger B, et al. Identification ofrelevant concepts of functioning in daily life in people with systemic lupus erythematosus: A patient Delphi exercise. Arthritis Rheum. 2009;61:21-8. doi: 10.1002/art.24165

16. Elera-Fitzcarrald C, Alva M, Gamboa-Cardenas R. Factors associated with health-related quality of life in Peruvian patients with systemic lupus erythematosus. Lupus. 2018;0:1-7. doi: 10.1177/0961203317751062

17. McElhone K, Castelino M, Abbott J, et al. The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosus. J Rheumatol. 2010;37:2273-9. doi: 10.3899/jrheum.091277

18. Alarcon GS, McGwin G Jr, Sanchez ML, et al. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum. 2004;51:73-7. doi: 10.1002/art.20085

19. Alarcon GS, Calvo-Alen J, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006;65:1168-74. doi: 10.1136/ard.2005.046896

20. Lotstein DS, Ward MM, Bush TM, et al. Socioeconomic status and health in women with systemic lupus erythematosus. J Rheumatol. 1998;25:1720-9.

21. Alarcon GS, McGwin G Jr, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum. 2001;44:2797-806. doi: 10.1002/1529-0131(200112)44:12<2797::AIDART467>3.0.CO;2-9

22. Rivest C, Lew RA, Welsing PM, et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J Rheumatol. 2000;27:680-4.

23. Sutcliffe N, Clarke AE, Gordon C, et al. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford). 1999;38:1130-7. doi: 10.1093/rheumatology/38.11.1130

24. Alarcon GS, McGwin G Jr, Bastian HM, et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 2001;45:191-202. doi: 10.1002/1529-0131(200104)45:2<191::AIDANR173>3.3.CO;2-U

25. Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine (Baltimore). 2006;85:147-56. doi: 10.1097/01.md.0000224709.70133.f7

26. Krishnan E. Hospitalization and mortality of patients with systemic lupus erythematosus. J Rheumatol. 2006;33:1770-4.

27. Ward M, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995;38:274-83. doi: 10.1002/art.1780380218

28. Bultink I, Turkstra F, Dijkmans B, et al. High Prevalence of Unemployment in Patients with Systemic Lupus Erythematosus: Association with Organ Damage and Health-Related Quality of Life. J Rheumatol. 2008;35;1053-7.

29. Jolly M, Mikolaitis R, Shakoor N. Education, Zip Code-based Annualized Household Income, and Health Outcomes in Patients with Systemic Lupus Erythematosus. J Rheumatol. 2010;37(6):1150-7. doi: 10.3899/jrheum.090862

30. Holloway L. Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance. Health Qual Life Outcomes. 2014;12:116. doi: 10.1186/s12955-014-0116-1

31. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus. 2006;15:308-18. doi: 10.1191/0961203306lu2305xx

32. Phillips RH. Coping with Lupus. Avery Penguin Putnam, New York 2001; Wallace D. The Lupus Book. A Guide for Patients and Their Familes. Oxford: Oxford University Press; 2005.

33. Katz P, Morris A, Trupin L, et al. Disability in valued life activities among individuals with systemic lupus erythematosus. Arthritis Rheum. 2008;59(4):465-73. doi: 10.1002/art.23536

34. Tamayo T, Fischer-Betz R, Beer S, et al. Factors influencing the health related quality of life in patients with systemic lupus erythematosus: long-term results (2001-2005) of patients in the German Lupus Erythematosus Self-Help Organization LULA Study. Lupus. 2010;19:1. doi: 10.1177/0961203310377090

35. Mattsson M, Moller B, Stamm T, et al. Uncertainty and opportunities in patients with established systemic lupus erythematosus: a qualitative study. Musculoskelet Care. 2012;10:1-12. doi: 10.1002/msc.220

36. Williams EM, Zhang J, Anderson J, et al. Social support and selfreported stress levels in a predominantly African American sample of women with systemic lupus erythematosus. Autoimmun Dis. 2015;2015:401620. doi: 10.1155/2015/401620

37. Dantzer R. Cytokine, sickness behavior, and depression. Immunol Allergy Clin North Am. 2009;29(2):247-64. doi: 10.1016/j.iac.2009.02.002

38. Piper BF. Pathophysiological Phenomena in Nursing: Human Responses to Illness. PA, USA: WB Saunders; 1993. P. 279-302.

39. Ahn GE, Ramsey-Goldman R. Fatigue in systemic lupus erythematosus. Int J Clin Rheumatol. 2012;7:217-27. doi: 10.2217/ijr.12.4

40. Tench CM, Mccurdie I, White PD, D'Cruz DP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford). 2000;39(11):1249-54. doi: 10.1093/rheumatology/39.11.1249

41. Zonana-Nacach A, Roseman JM, Mcgwin G Jr, et al. Systemic lupus erythematosus in three ethnic groups. VI: factors associated with fatigue within 5 years of criteria diagnosis. LUMINA study group. Lupus in minority populations: Nature vs Nurture. Lupus. 2000;9(2):101-9. doi: 10.1191/096120300678828046

42. Jump RL, Robinson ME, Armstrong AE, et al. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol. 2005;32(9):1699-705

43. Valencia-Flores M, Cardiel MH, Santiago V, et al. Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus. Lupus. 2004;13(1):4-10. doi: 10.1191/0961203304lu480oa

44. McKinley PS, Ouellette SC, Winkel GH. The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. Arthritis Rheum. 1995;38:826-34.

45. Cleanthous S, Tyagi M. What do we know about self-reported fatigue in systemic lupus erythematosus? Lupus. 2012;21:465-76. doi: 10.1177/0961203312436863

46. Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria for Fatigue; Measurement of fatigue in systemic lupus erythematosus: A systematic review. Arthritis Rheum. 2007 Dec 15;57(8):1348-57. doi: 10.1002/art.23113

47. Gladman D, Urowitz M. Systemic lupus erythematosus: Clinical and laboratory features. Primer on the rheumatic diseases. 11th ed. Atlanta, GA: Arthritis Foundation; 1997. P. 251-7.

48. Sfikakis P, Mitsikostas D, Manoussakis M, et al. Headache in systemic lupus erythematosus: A controlled study. Br J Rheumatol. 1998;37:300-3 doi: 10.1093/rheumatology/37.3.300.

49. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins lupus cohort. Lupus. 2000;9(3):170-5. doi: 10.1191/096120300678828226

50. Danoff-Burg S, Friedberg F. Unmet needs of patient with systemic lupus erythematosus. Behav Med. 2009;5:5-13. doi: 10.3200/BMED.35.1.5-13

51. Moses N, Wiggers J, Nicholas C, et al. Prevalence and correlates of perceived unmet needs of people with Systemic Lupus Erythematosus. Patient Educat Counsel. 2004;57(1):30-8. doi: 10.1016/j.pec.2004.03.015

52. Waldheim E, Elkan A-C, Pettersson S. Health-related quality of life, fatigue and mood in patients with SLE and high levels of pain compared to controls and patients with low levels of pain. Lupus. 2013;22(11):1118-27. doi: 10.1177/0961203313502109

53. Bachen E, Chesney M, Criswell L. Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus. Arthritis Rheum. 2009;61:822-9. doi: 10.1002/art.24519

54. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: pre- valence using standardized definitions. Neurology. 2002;58:1214-20. doi: 10.1212/WNL.58.8.1214

55. Julian L, Gregorich S, Tonner C. Using the Center for Epidemiologic Studies Depression Scale to screen for depression in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63:884-90. doi: 10.1002/acr.20447

56. Petri M, Naqibuddin M, Carson KA, et al. Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol. 2010;37:2032-8. doi: 10.3899/jrheum.091366

57. Van Exel E, Jacobs J, Korswagen L, et al. Depression in systemic lupus erythematosus, dependent on or independent of severity of disease. Lupus. 2013;22:1462-9. doi: 10.1177/0961203313508443

58. Maneeton B, Maneeton N, Louthrenoo W. Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study. Neuropsychiatr Dis Treat. 2013;9:799-804. doi: 10.2147/NDT.S44248

59. Macedo EA, Appenzeller S, Costallat LT. Gender differences in systemic lupus erythematosus concerning anxiety, depression and quality of life. Lupus. 2016;25:1315-27. doi: 10.1177/0961203316638934

60. Etchegaray-Morales I, Mendez-Martinez S, Jimenez-Hernandez C, et al. Factors Associated with Health-Related Quality of Life in Mexican Lupus Patients Using the LupusQol. PLoS One. 2017;12(1):e0170209. doi: 10.1371/journal.pone.0170209

61. Shen B, Tan W, Feng G et al. The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:270878.

62. Shakeri H, Arman F, Hossieni M. Depression, Anxiety and Disease-Related Variables and Quality of Life Among Individuals With Systemic Lupus Erythematosus Living in Kermanshah Province, Iran. Iran Red Crescent Med J. 2015 Dec;17(12):e31047. doi: 10.5812/ircmj.31047

63. Lederman L, Lindner H, Greenwood K, Philip E. Depression and pain in night time and daytime functioning of individuals with Lupus. Psychol Health. 2008;23(5):537-50. doi: 10.1080/08870440701724849

64. Kulczycka L, Sysa-Jedrzejowska A, Robak E. Life satisfaction together with positive and negative aspects in Polish patients with Systemic Lupus Erythematosus. Lupus. 2009;23(3):251-5. doi: 10.1111/j.1468-3083.2008.03044.x

65. Hawro T, Krupinska-Kun M, Rabe-Jabonska J, et al. Psychiatric disorders in patients with systemic lupus erythematosus: association of anxiety disorder with shorter disease duration. Rheumatol Int. 2011;31:1387-91. doi: 10.1007/s00296-010-1689-6

66. Kozora E, West SG, Kotzin BL, et al. Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum. 1998;41(1):41-7. doi: 10.1002/1529-0131(199801)41:1<41::AID-ART6>3.0.CO;2-7

67. Denburg S, Carbotte R, Ginsberg J, Denburg J. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc. 1997;3(4):377-86.

68. Denburg S, Carbotte R, Denburg J. Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits. J Clin Exp Neuropsychol. 1987;9(4):323-39.

69. Kozora E, Arciniegas DB, Filley CM, et al. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Arthritis Rheum. 2008;59(11):1639-46. doi: 10.1002/art.24189

70. Миллер Дж, Галантер Ю, Прибрам К. Планы и структуры поведения. Москва: Прогресс; 1985

71. Baddeley AD. Working memory. New York: Oxford University Press, 1986.

72. Dobrowolski C, Engel L, Green R, et al. Cognitive Impairment and Health-Related Quality of Life in a Lupus Cohort [abstract]. Arthritis Rheum. 2018;70(suppl 10). Available from: https://acrabstracts.org/abstract/cognitive-impairment-and-health-relatedquality-of-life-in-a-lupus-cohort/. Accessed March 29, 2019.

73. Costa DD, Bernatsky S, Dritsa M, et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum. 2005;53:272-8. doi: 10.1002/art.21069

74. Chandrasekhara PK, Jayachandran NV, Rajasekhar L, et al. The prevalence and associations of sleep disturbances in patients with systemic lupus erythematosus. Mod Rheumatol. 2009;19:407-15. doi: 10.3109/s10165-009-0185-x

75. Kasitanon N, Achsavalertsak U, Maneeton B, et al. Associated factors and psychotherapy on sleep disturbances in systemic lupus erythematosus. Lupus. 2013;22:1353-60. doi: 10.1177/0961203313507355

76. Mirbagher L, Gholamrezaei A, Hosseini N, Sayed Bonakdar Z. Sleep quality in women with systemic lupus erythematosus: contributing factors and effects on health-related quality of life. Int J Rheum Dis. 2014;19(3):305-11. doi: 10.1111/1756-185x.12418

77. Асеева EA, Амирджанова BH, Лисицына TA, Завальская MB. Качество жизни у больных системной красной волчанкой. Научно-практическая ревматология. 2013;51(3):324-31 doi: 10.14412/1995-4484-2013-1508

78. Ji L, Lili S, Jing W, et al. Appearance concern and depression in adolescent girls with systemic lupus erythematous. Clin Rheumatol. 2012;31:1671-5. doi: 10.1007/s10067-012-2071-8

79. Garcia Morales M, Callejas Rubio J, Peralta-Ramirez M, et al. Impaired sexual function in women with systemic lupus erythematosus: a cross-sectional study. Lupus. 2013;22:987-95. doi: 10.1177/0961203313500370

80. Hale ED, Treharne GJ, Norton Y, et al. Concealing the evidence': the importance of appearance concerns for patients with systemic lupus erythematosus. Lupus. 2006;15:532-40. doi: 10.1191/0961203306lu2310xx

81. Daleboudt GMN, Broadbent E, McQueen F, Kaptein AA. The impact of illness perceptions on sexual functioning in patients with systemic lupus erythematosus. J Psychosom Res. 2013;74:260-4. doi: 10.1016/j.jpsychores.2012.11.004

82. De Ferreira CC, da Mota LMH, Oliveira ACV, et al. Frequency of sexual dysfunction in women with rheumatic diseases. Rev Bras Reumatol. 2013;53:35-46. doi: 10.1016/S2255-5021(13)70004-X

83. Seawell A, Danoff-Burg S. Body image and sexuality in women with and without Systemic Lupus Erythematosus. Sex Roles. 2005;53(11-12):865-83. doi: 10.1007/s11199-005-8298-y


Для цитирования:


Воробьева Л.Д. Факторы, влияющие на качество жизни, связанное со здоровьем, у пациентов с системной красной волчанкой. Научно-практическая ревматология. 2019;57(4):462-467. https://doi.org/10.14412/1995-4484-2019-462-467

For citation:


Vorobyeva L.D. FACTORS INFLUENCING HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS. Rheumatology Science and Practice. 2019;57(4):462-467. (In Russ.) https://doi.org/10.14412/1995-4484-2019-462-467

Просмотров: 55


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1995-4484 (Print)
ISSN 1995-4492 (Online)